Impact of cranial and axillary/subclavian artery involvement by color duplex sonography on response to treatment in giant cell arteritis

被引:42
|
作者
Czihal, Michael [1 ]
Piller, Anne [1 ]
Schroettle, Angelika [1 ]
Kuhlencordt, Peter [1 ]
Bernau, Christoph [3 ,4 ]
Schulze-Koops, Hendrik [2 ]
Hoffmann, Ulrich [1 ]
机构
[1] Munich Univ Hosp, Div Vasc Med, D-80336 Munich, Germany
[2] Munich Univ Hosp, Div Rheumatol & Clin Immunol, D-80336 Munich, Germany
[3] Munich Univ Hosp, Med Clin & Policlin 4, D-80336 Munich, Germany
[4] Munich Univ Hosp, Dept Med Informat Biometry & Epidemiol, D-80336 Munich, Germany
关键词
PLACEBO-CONTROLLED TRIAL; LARGE-VESSEL INVOLVEMENT; DOUBLE-BLIND; METHOTREXATE; THERAPY; ULTRASONOGRAPHY; FEMOROPOPLITEAL; INTERLEUKIN-6; DURATION;
D O I
10.1016/j.jvs.2014.12.045
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Color duplex sonography (CDS) today is broadly used in the diagnostic workup of patients with suspected cranial or extracranial giant cell arteritis (GCA). This study aimed to determine the prognostic impact of the disease pattern assessed by CDS on the treatment response in GCA. Methods: This was a retrospective, longitudinal follow-up study of 43 patients who were diagnosed with GCA at our institution between 2002 and 2010. All patients underwent CDS of the temporal and subclavian/axillary arteries at baseline and were observed for at least 6 months. Vasculitis was sonographically characterized by a circumferential, hypoechogenic wall thickening. According to the CDS findings, patients were categorized into patients with involvement of the subclavian/axillary arteries only (group A1, n = 17), patients with involvement of both the subclavian/axillary arteries and the temporal arteries (group A2, n = 9), and patients with isolated cranial GCA (group B, n = 17). Data on recurrences, corticosteroid doses, and steroid-sparing agents were extracted from the medical records. Treatment response over time was analyzed by Kaplan-Meier curves with log-rank testing. Results: The mean follow-up time was 25.4 months and did not differ between groups (P = .4). Patients in group A1 were significantly younger than patients in groups A2 and B (P < .01). The interval between symptom onset and diagnosis was significantly longer in groups A1 and A2 compared with group B (P < .01). The number of recurrences per month was significantly higher in group A2 compared with group A1 and group B (A1, 0.07; A2, 0.13; B, 0.03; P < .01). Whereas there were no significant differences in the mean time until a daily prednisolone dose <10 mg was reached, patients in group A2 more frequently required steroid-sparing agents (A1, 24%; A2, 56%; B, 24%; P = .04). Conclusions: Extensive vascular involvement of both the temporal and subclavian/axillary arteries, as depicted by CDS, may be associated with a poor treatment response in GCA.
引用
收藏
页码:1285 / 1291
页数:7
相关论文
共 50 条
  • [41] Neurologic involvement in Giant Cell Arteritis: Treatment and outcome
    GonzalezGay, MA
    Blanco, R
    RodriguezValverde, V
    MartinezTaboada, VM
    Uriarte, E
    Figueroa, M
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 230 - 230
  • [42] The search for improvement in the sensitivity of temporal artery biopsy in giant cell arteritis Use of colour duplex sonography-guided temporal artery biopsy
    Gonzalez-Gay, Miguel A.
    Pina, Trinitario
    Blanco, Ricardo
    RHEUMATOLOGY, 2015, 54 (03) : 379 - 380
  • [43] CRANIAL, EXTRACRANIAL AND MIXED INVOLVEMENT IN GIANT CELL ARTERITIS: ANALYSIS OF THE CLINICAL DIFFERENCES
    Uyaguari Morocho, M. D. C.
    Fernandez-Fernandez, E.
    Monjo, I.
    de Miguel, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 650 - 651
  • [44] Patient-reported involvement of the eighth cranial nerve in giant cell arteritis
    Saravanan, Vadivelu
    Pugmire, Susan
    Smith, Mavis
    Kelly, Clive
    CLINICAL RHEUMATOLOGY, 2019, 38 (12) : 3655 - 3660
  • [45] Patient-reported involvement of the eighth cranial nerve in giant cell arteritis
    Vadivelu Saravanan
    Susan Pugmire
    Mavis Smith
    Clive Kelly
    Clinical Rheumatology, 2019, 38 : 3655 - 3660
  • [46] Diagnostic value of axillary artery ultrasound in patients with suspected giant cell arteritis
    Hop, Hilde
    Mulder, Douwe J.
    Sandovici, Maria
    Glaudemans, Andor W. J. M.
    van Roon, Arie M.
    Slart, Riemer H. J. A.
    Brouwer, Elisabeth
    RHEUMATOLOGY, 2020, 59 (12) : 3676 - 3684
  • [47] Temporal artery biopsy versus imaging in patients with cranial giant cell arteritis
    Edsel Ing
    La radiologia medica, 2020, 125 : 902 - 903
  • [48] Bilateral axillobrachial and external carotid artery manifestation of giant cell arteritis:: important role of color duplex ultrasonography in the diagnosis
    Kolossváry, E
    Kollár, A
    Pintér, H
    Erényi, É
    Kiséry, I
    Péter, H
    Farkas, K
    Mogán, L
    Farsang, C
    Kiss, I
    INTERNATIONAL ANGIOLOGY, 2005, 24 (02) : 202 - 205
  • [49] Temporal artery biopsy versus imaging in patients with cranial giant cell arteritis
    Ing, Edsel
    RADIOLOGIA MEDICA, 2020, 125 (09): : 902 - 903
  • [50] The Impact of Large Vessel Vasculitis of the Axillary Artery on Cumulative Glucocorticoid Dose and Relapse Rate in Giant Cell Arteritis
    Bosch, Philipp
    Dejaco, Christian
    Schmidt, Wolfgang
    Krause, Andreas
    Schlueter, Kenny-Davis
    Pregartner, Gudrun
    Schaefer, Valentin
    ARTHRITIS & RHEUMATOLOGY, 2020, 72